HUP0104367A2 - 8-Ciano-1-ciklopropil-7-(1S,6S-2.8-diazabiciklo[4.3.0]-nonán-8-il)-6-fluor-1,4-dihidro-4-oxo-3-kinolinkarbonsav szemi-hidrokloridja, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmények - Google Patents

8-Ciano-1-ciklopropil-7-(1S,6S-2.8-diazabiciklo[4.3.0]-nonán-8-il)-6-fluor-1,4-dihidro-4-oxo-3-kinolinkarbonsav szemi-hidrokloridja, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0104367A2
HUP0104367A2 HU0104367A HUP0104367A HUP0104367A2 HU P0104367 A2 HUP0104367 A2 HU P0104367A2 HU 0104367 A HU0104367 A HU 0104367A HU P0104367 A HUP0104367 A HU P0104367A HU P0104367 A2 HUP0104367 A2 HU P0104367A2
Authority
HU
Hungary
Prior art keywords
nonan
diazabicyclo
cyan
cyclopropyl
dihydro
Prior art date
Application number
HU0104367A
Other languages
English (en)
Inventor
Thomas Himmler
Hubert Rast
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of HUP0104367A2 publication Critical patent/HUP0104367A2/hu
Publication of HUP0104367A3 publication Critical patent/HUP0104367A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
HU0104367A 1998-11-25 1999-11-15 Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical composition thereof HUP0104367A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854357A DE19854357A1 (de) 1998-11-25 1998-11-25 Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PCT/EP1999/008778 WO2000031077A1 (de) 1998-11-25 1999-11-15 Semi-hydrochlorid von 8-cyan-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluor-1, 4-dihydro-4- oxo-3- chinolincarbonsäure

Publications (2)

Publication Number Publication Date
HUP0104367A2 true HUP0104367A2 (hu) 2002-02-28
HUP0104367A3 HUP0104367A3 (en) 2002-12-28

Family

ID=7888961

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104367A HUP0104367A3 (en) 1998-11-25 1999-11-15 Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical composition thereof

Country Status (28)

Country Link
US (1) US6995170B1 (hu)
EP (1) EP1133495B1 (hu)
JP (1) JP2002530408A (hu)
KR (1) KR100740956B1 (hu)
CN (1) CN1176921C (hu)
AR (1) AR023709A1 (hu)
AT (1) ATE225790T1 (hu)
AU (1) AU759769B2 (hu)
BR (1) BR9915684A (hu)
CA (1) CA2351714C (hu)
CZ (1) CZ300058B6 (hu)
DE (2) DE19854357A1 (hu)
DK (1) DK1133495T3 (hu)
ES (1) ES2181488T3 (hu)
HK (1) HK1042704B (hu)
HU (1) HUP0104367A3 (hu)
IL (2) IL142837A0 (hu)
NO (1) NO318053B1 (hu)
NZ (1) NZ511863A (hu)
PL (1) PL196508B1 (hu)
PT (1) PT1133495E (hu)
RU (1) RU2242475C2 (hu)
SK (1) SK285561B6 (hu)
TR (1) TR200101443T2 (hu)
TW (1) TWI234565B (hu)
UA (1) UA67875C2 (hu)
WO (1) WO2000031077A1 (hu)
ZA (1) ZA013317B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102006049520A1 (de) * 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
WO2018146194A1 (en) 2017-02-13 2018-08-16 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
DK0882049T3 (da) * 1996-02-23 2003-03-03 Bayer Ag Eventuelt substituerede 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer og deres derivater
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Also Published As

Publication number Publication date
NO318053B1 (no) 2005-01-24
PL196508B1 (pl) 2008-01-31
EP1133495B1 (de) 2002-10-09
BR9915684A (pt) 2001-08-14
CN1328557A (zh) 2001-12-26
AU1271600A (en) 2000-06-13
TR200101443T2 (tr) 2001-09-21
EP1133495A1 (de) 2001-09-19
DK1133495T3 (da) 2003-02-10
SK6842001A3 (en) 2001-12-03
ZA013317B (en) 2002-06-26
JP2002530408A (ja) 2002-09-17
US6995170B1 (en) 2006-02-07
IL142837A0 (en) 2002-03-10
CZ20011753A3 (cs) 2001-09-12
KR100740956B1 (ko) 2007-07-19
NO20012532D0 (no) 2001-05-23
ES2181488T3 (es) 2003-02-16
NO20012532L (no) 2001-07-02
KR20010075694A (ko) 2001-08-09
IL142837A (en) 2006-08-01
HK1042704A1 (en) 2002-08-23
DE59903063D1 (de) 2002-11-14
HK1042704B (zh) 2005-09-09
CA2351714C (en) 2010-06-15
TWI234565B (en) 2005-06-21
UA67875C2 (uk) 2004-07-15
PL347799A1 (en) 2002-04-22
CN1176921C (zh) 2004-11-24
RU2242475C2 (ru) 2004-12-20
DE19854357A1 (de) 2000-05-31
PT1133495E (pt) 2003-02-28
CA2351714A1 (en) 2000-06-02
SK285561B6 (sk) 2007-03-01
WO2000031077A1 (de) 2000-06-02
ATE225790T1 (de) 2002-10-15
AR023709A1 (es) 2002-09-04
HUP0104367A3 (en) 2002-12-28
NZ511863A (en) 2003-05-30
CZ300058B6 (cs) 2009-01-21
AU759769B2 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HUP0000450A3 (en) The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
HUP0101813A3 (en) Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them
IL119795A0 (en) Crystalline 1-cyclopropyl-7-([S,S]-2,9-diazabicyclo-[4.3.0]non-8-YL) 6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride its preparation and pharmaceutical formulations containing it
HUP0200807A2 (hu) Helyettesített propánsavszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0000728A3 (en) Salt of naphthyridine carboxylic acid derivative, process for producing it and pharmaceutical composition containing it
HUP9904703A3 (en) Aminothiophene carboxylic acid amides, pharmaceutical compositions containing them and process for their preparation
HUP0300188A3 (en) Carboxylic acid derivatives as ip antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0103987A3 (en) Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
EP1411056A3 (en) Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
HUP0104713A3 (en) Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions thereof
HUP0104367A3 (en) Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical composition thereof
HUP0004704A3 (en) Dihydrofuro [3,4-b] quinolin-1-one derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0104465A3 (en) Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical composition thereof
HUP0200006A3 (en) Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8-diazabicyclo - [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid process for their preparation, pharmaceutical composition comprising thereof and their use
HUP0200053A3 (en) Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same
HUP0201321A3 (en) New betha-amide and betha-sulfonamide carboxylic acid derivatives, their preparation and pharmaceutical compositions containing the compounds
HUP0202265A3 (en) Oxathiepino [6,5-b] dihydropyridines, process for their preparation, pharmaceutical compositions containing them and an apparatus for administering the same
IL108495A0 (en) Carboxylic acid amide derivatives, pharmaceutical compositions containing same, and processes for the preparation thereof
AU2691900A (en) 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished